Cancer
Salani Reviews Options for a Patient With Metastatic Endometrial Cancer
A cohort of patients had previously [managed] MSI-H/dMMR advanced endometrial cancer. They were treated with pembrolizumab every 3 weeks for 2 years …
A cohort of patients had previously [managed] MSI-H/dMMR advanced endometrial cancer. They were treated with pembrolizumab every 3 weeks for 2 years …
:max_bytes(150000):strip_icc():focal(749x0:751x2)/Shannen_Doherty_2-b9a70701a60e447a8707567e2db92a0a.jpg)
:max_bytes(150000):strip_icc():focal(749x0:751x2)/People_Shannen_Doherty_Cover-TOUT-5ff5a509ba4543f4a45c03218c48240d.jpg)
